Umbilical Cord Blood
8
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (8)
Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Performance Evaluation of the ex Utero Cord Blood Collection Technique: Procedure, Quality and Results
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure